Assistant Professor, Department of General Medicine, Sri Lakshminarayana Institute of Medical Sciences, Puducherry, India
moxifloxacin ,prospective study ,

Pneumonia acquired from the Community (CAP) is one of the world's most commonly reported infectious illnesses. The incidence of CAP in different nations has been observed, from 1.6 to 11 per 1 000 adult population, although it is impossible to produce precise estimates due to the absence of a standard CAP diagnostic approach. CAP is a key source of morbidity, hospitalisation, mortality, decreased life quality and a major social health burden. CAP Western India has a hospitalisation incidence of 10% to 60% for CAP patients depending on the patient community. The study was conducted to evaluate the distribution of the severity index of CRB-65 in base-line patients in CAP hospitals. The CRB-65 is a validated instrument for the risk assessment that is easy to select CAP therapy alternatives. In this broad observer sample from all Indian countries, the efficacy and safety profiles of moxifloxacin confirm prior results indicating moxifloxacin is useful for the therapy of the CAP patients. The The strong response rate in the present trial, including patients with a diversity of disease severity, shows that broader spectrum medicines such as moxifloxacin can be administered in hospitals in CAP patients.

2 , 2 , 2012